August 5, 2010 – Chronic pain is a serious medical problem, afflicting approximately 20% of adults. Some individuals are more susceptible than others, and the basis for this remains largely unknown. In a report published online today in Genome Research (http://www.genome.org), researchers have identified a gene associated with susceptibility to chronic pain in humans, signaling a significant step toward better understanding and treating the condition.
The degree of pain experienced after injury or surgery is known to be highly variable between patients, even under nearly identical circumstances, prompting researchers to search for the contribution of genetics to chronic pain susceptibility. To accelerate research in this field, animal models are proving to be critical to understanding the underlying biology of chronic pain in human patients.
Recently, using a mouse model of chronic pain, Ariel Darvasi of the Hebrew University of Jerusalem and colleagues identified a region of mouse chromosome 15 that likely contained a genetic variant or variants contributing to pain. However, this region contains many genes and the responsible variant remained unknown.
Darvasi and an international team of researchers have now undertaken two fine-mapping approaches to narrow down the locus to an interval of 155 genes. Then, by applying bioinformatics approaches and whole genome microarray analysis, they were able to confidently identify a single gene, Cacgn2, as the likely candidate. This gene is known to be involved in cerebellar function and epilepsy, but a functional link to pain had not been described previously.
To further test the potential role for Cacgn2 in chronic pain, the authors utilized a mouse strain harboring a mutant version of the gene that had previously been used in epilepsy research. In testing the mice for behavioral and electrophysological characteristics of chronic pain, they found that, although modest, the observations were consistent with a functional role for Cacgn2 in pain.
However, the question still remained as to whether the human version of the gene, CACGN2, also is important for chronic pain. Analyzing a cohort of breast cancer patients that had undergone removal or partial removal of a breast, they found known genetic polymorphisms in CACNG2 were significantly associated with chronic pain experienced after surgery. The authors cautioned that although this association will need to be analyzed further, the result is encouraging.
"The immediate significance is the mere awareness that differences in pain perception may have a genetic predisposition," Darvasi explained. "Our discovery may provide insights for treating chronic pain through previously unthought-of mechanisms."
Scientists from The Hebrew University of Jerusalem (Jerusalem, Israel), the University of Toronto (Toronto, Canada), Sanofi-Aventis Germany (Frankfurt am Main, Germany), and the Karolinska Institute Center for Oral Biology (Huddinge, Sweden) contributed to this study.
This work was supported by the Israel Science Foundation, The Hebrew University Center for Research on Pain, the Canada Research Chair Program, and the European Community's 6th Framework Program.
Media contacts: The authors are available for more information by contacting Orit Sulitzeanu, Director of the Department of Media Relations at the Hebrew University of Jerusalem (firstname.lastname@example.org; +972-2-5882811).
Interested reporters may obtain copies of the manuscript from Peggy Calicchia, Editorial Secretary, Genome Research (email@example.com; +1-516-422-4012).
About the article:
The manuscript will be published online ahead of print on August 5, 2010. Its full citation is as follows: Nissenbaum J, Devor M, Seltzer Z, Gebauer M, Michaelis M, Tal M, Dorfman R, Abitbul-Yarkoni M, Lu Y, Elahipanah T, delCanho S, Minert A, Fried K, Persson A, Shpigler H, Shabo E, Yakir B, Pisante A, Darvasi A. Susceptibility to chronic pain following nerve injury is genetically affected by CACNG2. Genome Res doi:10.1101/gr.104976.110.
About Genome Research:
Launched in 1995, Genome Research (www.genome.org) is an international, continuously published, peer-reviewed journal that focuses on research that provides novel insights into the genome biology of all organisms, including advances in genomic medicine. Among the topics considered by the journal are genome structure and function, comparative genomics, molecular evolution, genome-scale quantitative and population genetics, proteomics, epigenomics, and systems biology. The journal also features exciting gene discoveries and reports of cutting-edge computational biology and high-throughput methodologies.
About Cold Spring Harbor Laboratory Press:
Cold Spring Harbor Laboratory is a private, nonprofit institution in New York that conducts research in cancer and other life sciences and has a variety of educational programs. Its Press, originating in 1933, is the largest of the Laboratory's five education divisions and is a publisher of books, journals, and electronic media for scientists, students, and the general public.
Genome Research issues press releases to highlight significant research studies that are published in the journal.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.